|
⚲
|
| Keyboard |
| Sigal Charles Elliott
✚
|
|
|---|---|
| CIK # | 0001661908 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001661908] | |
| 4 | [0001661908] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sigal Charles Elliott | |
| Vir Biotechnology Inc | |
| Alnylam Pharmaceuticals Inc | |
| Surface Oncology Inc | |
| Adaptimmune Therapeutics PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vir Biotechnology Inc VIR
Stock Option (Right to Buy) · derivative
|
2025-05-30 | Grant | 16,000 | $0.00 | |
|
Vir Biotechnology Inc VIR
Common Stock
|
2025-05-30 | Grant | 8,000 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 1,558 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2025-05-08 | Grant | 775 | $0.00 | |
|
Vir Biotechnology Inc VIR
Common Stock
|
2024-05-30 | Grant | 8,000 | $0.00 | |
|
Vir Biotechnology Inc VIR
Stock Option (Right to Buy) · derivative
|
2024-05-30 | Grant | 16,000 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (right to buy) · derivative
|
2024-05-16 | Grant | 5,228 | $0.00 | |
|
Surface Oncology Inc SURF
Common Stock
|
2023-09-08 | Disposed to issuer | 45,453 | ||
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2023-09-08 | Disposed to issuer | 113,636 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2023-07-03 | Grant | 933,317 | $0.00 | |
|
Vir Biotechnology Inc VIR
Common Stock
|
2023-05-22 | Grant | 6,027 | $0.00 | |
|
Vir Biotechnology Inc VIR
Stock Option (Right to Buy) · derivative
|
2023-05-22 | Grant | 12,054 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (right to buy) · derivative
|
2023-05-18 | Grant | 3,454 | $0.00 | |
|
Vir Biotechnology Inc VIR
Common Stock
|
2023-03-01 | Buy | 2,500 | $22.73 | 56,825 |
|
Vir Biotechnology Inc VIR
Common Stock
|
2023-01-05 | Buy | 2,500 | $24.96 | 62,400 |
|
Vir Biotechnology Inc VIR
Common Stock
|
2023-01-04 | Buy | 2,500 | $25.25 | 63,125 |
|
Vir Biotechnology Inc VIR
Common Stock
|
2023-01-03 | Buy | 2,500 | $25.60 | 64,000 |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (right to buy) · derivative
|
2022-08-22 | Grant | 4,456 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2022-07-01 | Grant | 737,050 | $0.00 | |
|
Surface Oncology Inc SURF
Stock Option (Right to Buy) · derivative
|
2022-06-08 | Grant | 24,000 | $0.00 | |
| showing 20 of 43 most recent transactions | |||||